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In vitroIn vitro toxicological studies for tobacco product assessment have traditionally been undertaken using the
particulate phase of tobacco smoke. However, this does not truly reﬂect exposure conditions that occur in
smokers. Thus in vitro cell culture systems are required in which cells are exposed to tobacco whole
smoke (WS) at the air–liquid interface (ALI). In this study bronchial epithelial cells were cultured on
semi-permeable membranes, transitioned to the ALI and the robustness and sensitivity of the cells to
tobacco WS and vapour phase (VP) assessed. Although no effect of air exposure was observed on cell via-
bility, IL-6 and IL-8 release was increased. Exposure to WS resulted in a signiﬁcant dose dependent
decrease in cell viability and a signiﬁcant non-dose dependent increase in inﬂammatory mediator secre-
tion. The VP was found to contribute approximately 90% of the total cytotoxicity derived from WS. The
cell culture system was also able to differentiate between two smoking regimens and was sensitive to
passage number with increased inﬂammatory mediator secretion and lower cell viability observed in cell
cultures of low passage number following WS exposure. This simple cell culture system may facilitate
studies on the toxicological impact of future tobacco products and nicotine delivery devices.
 2015 The Authors. Published by Elsevier Ltd. This is an openaccess article under the CCBY license (http://
creativecommons.org/licenses/by/4.0/).1. Introduction
Tobacco smoke is a complex, dynamic, mixture of more than
6000 identiﬁed constituents (Rodgman and Perfetti, 2013), of
which approximately 150 have been documented as toxicants
(Fowles and Dybing, 2003). Long-term exposure to these and other
smoke chemicals is thought to drive the development of many
smoking-related diseases (US Department of Health and Human
Services, 2004) including chronic obstructive pulmonary disease
(COPD). COPD is a major public health issue and is the fourth lead-
ing cause of death in the United States and Canada and by the year
2020 it is predicted to become the third most frequent cause of
death and the ﬁfth most frequent cause of chronic disability
(Lopez and Murray, 1998). Although the precise etiology of COPD
is unknown, the condition appears to be associated with
long-term exposure to toxic aerosols and particles, however, the
vast majority of cases are due to tobacco smoking (Sethi and
Rochester, 2000). There is therefore a need to gain a better under-
standing of the mechanisms associated with the development of
this disease, particularly as a consequence of tobacco smokeexposure. This knowledge may potentially aid in more effective
disease speciﬁc treatments and in the development of new,
tobacco related, harm reduction technologies.
Traditionally, the toxicological evaluation of tobacco whole
smoke (WS) primarily focused on the particulate fraction and
to date this fraction continues to be investigated both for regu-
latory and research purposes. Particulate matter is often col-
lected by passing WS through a Cambridge ﬁlter pad, eluting
the trapped particulates with an organic solvent and then apply-
ing this solution to submerged cell culture systems to assess cel-
lular responses. As this fraction only constitutes 5–10% of the
WS generated from burning tobacco (Keith and Tesh, 1965),
the remaining fraction is not assessed by this approach. To over-
come this problem and thus to capture components from both
the vapour and particulate phases, WS can either be bubbled
through a biological buffer or cell culture medium. The resulting
‘aqueous extract’ can then be used in a variety of in vitro test
systems (Cantrall et al., 1995; Bernhard et al., 2004; Carnevali
et al., 2006; Cervellati et al., 2014), in particular those tests in
which endothelial cell functions are being assessed. However,
many of the non-aqueous soluble chemicals in smoke will not
be trapped and as many lung cell culture systems are sub-
merged, the results of these exposure studies may not truly
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assess the biological effects of WS on the lung, an in vitro cell
culture system is required that can deliver WS to lung cells
exposed at the air–liquid interface (ALI) (CORESTA, 2005).
Over the last few years there has been an increase in the
development of both in vitro ALI cultures (Kreft et al., 2014;
Carson et al., 2014; Mathis et al., 2013) and WS generation
and delivery systems (Thorne et al., 2013; Thorne and
Adamson, 2013; Kaur et al., 2010; Aufderheide, 2008). The com-
bination of these two allow for well-deﬁned aerosols to be deliv-
ered to lung cells in culture that more closely represents what
happens in the lungs of smokers. One way in which this has
been achieved is through the use of the Borgwaldt RM20S smok-
ing machine coupled to an ALI cell culture system using either
cell lines or primary cell cultures (Phillips et al., 2005;
Maunders et al., 2007; Adamson et al., 2011). However, to
ensure that these ALI culture systems are ﬁt for the assessment
of conventional and next generation tobacco products, electronic
cigarettes and tobacco heating devices, their robustness and sen-
sitivity requires further assessment. The robustness of an assay
can be deﬁned as the measure of its capacity to remain unaf-
fected by small, but deliberate variations in method parameters
and provides an indication of its reliability during normal usage.
Sensitivity is deﬁned as the ability of the model to differentiate
between different tobacco aerosols.
In the current study, the stability of a simple cell culture system,
utilising a bronchial epithelial cell line exposed at the ALI was
assessed. Robustness was measured by addressing the cytotoxic
and inﬂammatory response of the culture to WS and vapour phase
(VP) exposure at different cell seeding densities and passage num-
bers. Sensitivity was assessed by measuring the cell cultures
response to different fractions of tobacco smoke and following
exposure of WS generated under two smoking regimens.2. Materials and methods
2.1. Chemicals and reagents
Chemicals and reagents were obtained from the following
sources: Dulbecco’s Modiﬁed Eagle Medium, RPMI-1640 medium,
Hanks’ Balanced Salt Solution, Penicillin–Streptomycin solution,
L-glutamine, phosphate buffered saline (PBS), Transwell culture
inserts (12 mm or 24 mm diameter, 0.4 lM pore size) and tryp-
sin–EDTA from Fisher Scientiﬁc (Loughborough, UK); glacial acetic
acid and neutral red solution from Sigma–Aldrich™ (Poole, UK);
fetal bovine serum (FBS) and UltraCULTURE™ from Lonza (Basel,
Switzerland); interleukin-6 and -8 (IL-6 and IL-8) and matrix
metalloproteinase-1 (MMP-1) single plex electrochemilumines-
cence assays from Meso Scale Discovery (Gaithersburg, USA);
NCI-H292 human bronchial epithelial cells from the American
Type Culture Collection (Middlesex, UK: cell no. CRL-1848); 3R4F
reference cigarettes from the University of Kentucky (Kentucky,
USA).
2.2. Cell culture
A bronchial epithelial cell line (NCI-H292) was cultured in
RPMI-1640 cell culture medium supplemented with 10% FBS,
2 mM L-glutamine, 50 U/mL penicillin and 50 lg/mL strepto-
mycin in an incubator at 37 C, 5% CO2. Forty eight hours prior
to WS exposure, cells were seeded on the apical side of 12 mm
Transwell culture inserts, in sterile 12 well plates, at a density
of 3  105 cells/mL in 0.5 mL of supplemented RPMI-1640. For
each culture insert, 1 mL of supplemented RPMI-1640 was also
placed in the basal compartment of each well. During therobustness assessment, cells were recovered from liquid nitrogen
at passage 83, some were expanded until passage 89 (Low-P)
and others to passage 99 (High-P). The cells were then seeded
at either 2.85 (Low-SD) or 3.15 (High-SD)  105 cells/mL (±5%
of the standard seeding density) to give four cell culture groups
(1. Low-SD, Low-P; 2. Low-SD, High-P; 3. High-SD, Low-P and 4.
High-SD, High-P). All cell cultures were maintained at 37 C, 5%
CO2 for 24 h until a conﬂuent monolayer was achieved. Twenty
four hours before WS exposure the basal and apical cell culture
media were replaced with 1 mL and 0.5 mL respectively of
UltraCULTURE™ containing 2 mM glutamine, 50 U/mL penicillin
and 50 lg/mL streptomycin.
2.3. Study design
The study was designed in three stages and at every stage mea-
surements of cell viability and the concentration of secreted
inﬂammatory and tissue remodelling mediators were measured.
Firstly, to assess stability, cultures were maintained at the ALI,
without WS exposure, for up to 3 h. The cytotoxic and inﬂamma-
tory mediator response following a 30 min exposure to WS and
VP were also undertaken. Secondly, to determine the robustness
of the cell culture system, the effect of cell seeding density and pas-
sage number on the cytotoxic and inﬂammatory response to WS
and VP exposure were measured. Thirdly, the sensitivity of the
model was assessed by measuring the responses of the cell culture
system to WS and VP, and fromWS derived from two smoking reg-
imens; International Organization for Standardization (ISO) and
Health Canada Intense (HCI). In this third stage the initial seeding
density and passage number remained constant at 3  105 cells/mL
and 89 respectively.
2.4. Cigarettes and smoking
3R4F cigarettes were conditioned for a minimum of 48 h prior
to use (60 ± 3% relative humidity, 22 ± 1 C) and smoked in a test
atmosphere of 60 ± 5% relative humidity, 22 ± 2 C in accordance
with ISO 3402:1999. Cigarettes were either smoked according to
ISO 3308:2000 (35 mL puff volume, drawn over 2 s, once every
minute with ventilation holes unblocked) or to the HCI smoking
regimen (55 mL puff volume, drawn over 2 s, twice a minute
with ventilation holes blocked). For the ﬁrst two stages of the
study, six puffs were taken from each of ﬁve cigarettes using
the ISO 3308:2000 smoking regimen to give a total exposure
time of 30 min. For the third stage, in which cultures were
exposed to WS generated from the two smoking regimens, cells
were exposed to WS generated according to ISO 4387:2000
(whereby cigarettes were smoked to the length of the ﬁlter
+8 mm).
2.5. Tobacco whole smoke, vapour phase and air exposure
The WS exposure system used in this study has been described
previously (Adamson et al., 2011; Phillips et al., 2005; Thorne et al.,
2009; Maunders et al., 2007). Cells, prepared 24 h prior to expo-
sure, were transitioned to the ALI by removal of the covering apical
cell culture medium, transferred into a perspex aerosol exposure
chamber (Fig. 1) and then exposed for 30 min to dilutions
(1:500–1:2.5, smoke:air, vol:vol) of mainstream WS or VP using a
Borgwaldt RM20S smoking machine (Hamburg, Germany; Fig. 2).
VP exposure was achieved by the addition of an in-line
Cambridge ﬁlter pad to remove WS particulates.
During exposure, cells were fed basally with DMEM at a ﬂow
rate of 2 mL/min containing 50 U/mL penicillin and 50 lg/mL
streptomycin. Throughout WS and VP exposure, cell cultures were
maintained at 37 C. Following exposure, the culture inserts were
Fig. 1. Aerosol exposure chamber (A) and a schematic cross-section (B). The exposure chamber introduces the test aerosol through a single gas inlet. A symmetrical smoke
distribution plate ensures uniform cellular exposure (Thorne et al., 2013).
Fig. 2. A Borgwaldt RM20S smoking machine with 8 syringes. (A) Tobacco smoke
generator. (Bi and Bii) A syringe based dilution system with 4 syringes that can be
combined to give a total of 8. (C) Air ﬂow controller. (D) Cell culture medium
maintained at 37 C feeding exposure chambers with fresh cell culture medium. (E)
BAT exposure chamber housed at 37 C, attached to the smoke diluter and cell
culture medium (Adamson et al., 2011).
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supplemented UltraCULTURE™ pre-warmed at 37 C. 0.5 mL of
supplemented UltraCULTURE™ was added to the apical surface
of each culture insert and the cells incubated for a further 24 h at
37 C, 5% CO2 in a humidiﬁed atmosphere. Control cultures, in
which culture medium covering the apical surface of the cells
was removed, were either returned to the incubator (ALI) for
between 0.5 and 3 h, or exposed to a ﬂow of sterile laboratory air
at 200 cm3/min (AIR) for 30 min. An incubator control (INC) was
included in which cells were maintained submerged in culture
medium at 37 C and 5% CO2 throughout the exposure and 24 h
recovery period. Following the recovery period, culture medium
from the apical and basal compartments of each culture insert
and from all exposure studies were individually combined and
stored at80 C until the secreted inﬂammatory and tissue remod-
elling mediators were measured. Cell viability was measured using
the neutral red uptake assay. For comparison purposes cytotoxicity
curves were expressed either as a function of WS and VP dilution(smoke:air, vol:vol) or deposited total particulate matter
(lg PM/cm2).2.6. Tobacco whole smoke deposition
A chemical spectroﬂuorescence method was used to determine
the dose of WS cells received during the ISO and HCI smoking reg-
imen exposures (Adamson et al., 2011).2.7. Smoke chemistry analysis
Chemical analysis of mainstream WS was carried out as previ-
ously described (McAdam et al., 2012) and according to the smok-
ing conditions speciﬁed in ISO 4387:2000 with a modiﬁcation to
the smoking parameters as described by Gregg et al., 2004. In brief,
cigarettes were smoked to ISO or HCI regimens using a Borgwaldt
RM20 D smoking machine and the mainstreamWS passed through
a Cambridge ﬁlter pad to remove the particulate phase. The resul-
tant VP was collected into a 3L Tedlar bag. For particulate smoke
chemistry, trapped particulates were analysed in two ways; head-
space analysis for the volatile or semi-volatile compounds and sol-
vent extraction for analysis of constituents with a low vapour
pressure. VP analysis was undertaken according to the method
described by Dong et al. (2000).2.8. Cell viability assay
The neutral red uptake protocol was based on guidelines set
out by the National Institute of Health (National Institute of
Health, 2001). Culture medium was removed from exposed cells
whilst on culture inserts and washed twice with PBS. 0.5 mL and
1.0 mL of neutral red (0.05 g/L in UltraCULTURE™) was added
apically and basally respectively to the culture inserts and incu-
bated for 3 h at 37 C, 5% CO2 in a humidiﬁed atmosphere to
allow active uptake of the dye into viable cell lysosomes. To
remove unincorporated dye, the cells were washed twice with
PBS. Neutral red was eluted from cells by incubation with
500 lL of destain solution (50% ethanol, 49% distilled water, 1%
glacial acetic acid (vol:vol:vol)) and shaken gently for 10 min
at 300 rpm. 100 lL aliquots of the eluates were read on a
microplate spectrophotometer at 540 nm using a reference ﬁlter
of 630 nm. Background measurements from blank culture inserts
were subtracted from the neutral red uptake values of both
untreated and treated cells. Neutral red uptake levels of treated
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(AIR).2.9. Inﬂammatory and tissue remodelling mediator secretion
The concentrations of IL-6, IL-8 and MMP-1 in the cell culture
medium were measured as a single plex using MSD, a highly sen-
sitive electrochemiluminescence array method (Meso Scale
Discovery) in accordance with the manufacturers’ instructions.2.10. Statistical analysis
Data are reported either as means ± standard deviations (SD) or
boxplots ± range with each experiment conducted 3–6 times and
with three culture inserts per experiment.
Control culture comparisons were analysed using a one-way
analysis of variance (ANOVA) with differences between groups
determined using Tukey’s adjustment for multiple comparisons.
Neutral red cell viability data for WS and VP studies were mod-
elled using a 4-parameter sigmoid dose response curve with a vari-
able slope and the EC50 values determined. Comparisons betweenINC AIR 0.5h 1h 2h 3h
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Fig. 4. Inﬂammatory mediator secretion following WS and VP exposure. Data are expres
Air control, INC: Incubator control, ALI: Air–liquid interface control, WS: Whole smoke, V
dilutions (smoke:air, vol:vol). ⁄p < 0.05 compared to AIR controls.groups were undertaken using the F-test. All analyses were con-
ducted using GraphPad Prism version 6.00 for Windows,
GraphPad Software, CA, USA, www.graphpad.com.
For secreted inﬂammatory and tissue remodelling mediators,
comparisons between groups were made using the general lin-
ear model ANOVA with analysis of treated samples versus con-
trols performed using Tukey’s adjustment for multiple
comparisons. All analyses were conducted with Minitab ver-
sion 16. An unpaired t-test was performed on comparisons
between HCI and ISO at a single equivalent dose of
0.19 lg/cm2.
A 2 sample t-test was undertaken between HCI and ISO smoking
on each chemical constituent. A comparison of slopes and Y inter-
cepts from WS derived from the log10 transformed smoke dilution
– particulate deposition curves following ISO and HCI smoking was
undertaken using a linear regression analysis.
A p value of less than 0.05 was considered signiﬁcant.3. Results
3.1. The stability of NCI-H292 cells at the air–liquid interface
No signiﬁcant reduction in cell viability was observed for cells
cultured at the ALI for up to 3 h when compared to the INC controls
(Fig. 3). Remaining above 90%, the viability of cultures exposed to
AIR for 30 min was similar (p > 0.05) to the ALI (0.5 h) control,
but signiﬁcantly (p < 0.05) lower than that observed for the INC
controls.
No signiﬁcant differences in the concentrations of secreted
inﬂammatory mediators was observed between the INC and ALI
controls (Fig. 4). Exposure to a ﬂow of sterile air for 30 min resulted
in a signiﬁcant (p < 0.05) three to four-fold increase in IL-6 (ALI;
27 ± 7 pg/mL, INC; 26 ± 7 pg/mL, AIR; 104 ± 31 pg/mL) and IL-8
(ALI; 100 ± 78 pg/mL, INC; 97 ± 73 pg/mL, AIR; 335 ± 170 pg/mL)
secretion but not MMP-1 when compared to both the INC and
ALI controls.3.2. The effects of air, WS and VP exposure on NCI-H292 cell
cytotoxicity and inﬂammatory mediator secretion
The EC50 for WS exposure was 1:54 (smoke:air, vol:vol), a sig-
niﬁcantly greater dilution (p < 0.005) than that required following
exposure to VP alone (1:46) (Fig. 5). The average difference in cell
viability between the two dose response curves was 11%, and thus
VP constitutes 89% of the total toxicity of WS.posure
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which was equivalent to 95% cell viability, all secreted inﬂamma-
tory and tissue remodelling mediator concentrations were signiﬁ-
cantly (p < 0.05) increased when compared to the AIR controls
(Fig. 4). Exposure to the VP of 3R4F resulted in lower concentra-
tions of all inﬂammatory and tissue remodelling mediators when
compared to equivalent WS dilutions. IL-6 concentrations at the
three lowest dilutions of VP were signiﬁcantly (p < 0.05) lower
than those seen in the AIR controls.
3.3. The effects of passage number and cell density on cytotoxicity and
inﬂammatory mediator secretion following WS exposure
Cell viability of the INC and ALI control cultures, at different cell
densities and passage numbers, were not signiﬁcantly different
from each other (data not shown). There was a signiﬁcant
(p < 0.001) increase in cell viability with decreasing concentrations
of WS and VP (Fig. 6A) when data from all seeding densities and
passage numbers were combined. Cell viability was signiﬁcantly
higher in cultures exposed to VP (p < 0.001) and lower in low pas-
sage numbered cultures (Fig. 6C). No effect of seeding density was
observed (Fig. 6B).
Although no signiﬁcant effect of seeding density or passage
number was observed on control cultures (INC and AIR) for IL-6
secretion, there was a signiﬁcant effect of passage number on con-
stitutive IL-8 secretion. Cultures at higher seeding densities and
those derived from lower passaged numbered cells secreted more
IL-8 than equivalent cultures with lower seeding densities and
higher passage numbers following WS and VP exposure (Table 1).
3.4. Smoke chemistry
The results of standard smoke chemistry analyses for 3R4F gen-
erated under the ISO and HCI smoking regimens are shown in
Table 2 and Fig. 7.
HCI smoking resulted in statistically signiﬁcant (p < 0.001)
higher toxicant yields per tobacco for all constituents when com-
pared to ISO smoking (Fig. 7). When yields were expressed as a
function of TPM, per mg tar or per mg nicotine (data not shown)
the particulate based toxicants were generally lower, and the alde-
hydes higher when generated at HCI, compared to ISO. The WS
water and hydrogen cyanide content were also elevated following
HCI smoking and remained signiﬁcantly elevated regardless of the
normalisation of the data.3.5. Production of ISO and HCI particulate deposition graphs
No signiﬁcant effect of smoking regimen was observed either on
the slope or Y intercept (Fig. 8).
3.6. The effect of smoking regimen on cell viability and inﬂammatory
mediator release
The EC50 values for WS derived from the ISO and HCI regimens
were 2.3 and 4.0 lg/cm2 respectively with exposure to WS derived
from the ISO regimen signiﬁcantly (p < 0.001) more toxic than that
Table 2
Smoke yields for 3R4F generated under ISO and HCI machine smoking conditions.
Smoke constituent Unit Toxicant yield/tobacco
ISO ±SD HCI ±SD
NFDPM (Tar) mg/cig 8.00 0.48 27.69** 1.57
TPM mg/cig 9.46 0.63 49.13** 3.75
Nicotine mg/cig 0.69 0.04 1.98** 0.09
Carbon monoxide mg/cig 10.83 0.79 31.92** 1.41
Water mg/cig 0.77 0.19 19.46** 2.49
Results are displayed as the mean ± SD of 25 separate measurements. Data was
analysed using 2 sample t-test. NFDPM; Nicotine free dry particulate matter, TPM;
total particulate matter.
** p < 0.001 compared to the ISO smoking regimen.
Table 1
The effect of passage number (P) and seeding density (SD) on interleukin-6 (IL-6) and 8 (IL-8) secretion from bronchial cell cultures exposed to WS and VP at a dose equivalent to
95% cell viability.
Inﬂammatory mediator Exposure group Seeding density and passage number
High-SD, High-P High-SD, Low-P Low-SD, High-P Low-SD, Low-P
pg/mL
IL-6 AIR 78.7±31.2 73.0±26.0 67.0±30.8 65.4±21.0
INC 12.9±4.6 16.3±8.1 18.5±5.3 20.2±8.0
WS 87.2±46.8# 109±38.9#+ 93.1±36.0#+ 89.5±27.3+
VP 35.3±14.5# 36.2±16.3# 35.0±10.4# 35.6±11.2#
IL-8 AIR 169.7±141.3 280.7±127.3* 113.8±74.2 215.8±117.1*
INC 29.7±12.2 64.4±41.8* 38.0±16.2 71.3±43.6*
WS 267.1±127.8# 447±217*,+ 222±116# 393±168*,+
VP 128.6±77.4 208.0±120.4* 109.2±60.6 200.5±86.5*
Data represented as means and standard deviation for three replicate cell cultures and six independent experiments. AIR: Air control, INC: Incubator control, ALI: Air-liquid
interface control, WS: Whole smoke, VP: Vapour phase, High-SD: high seeding density, Low-SD: Low seeding density, High-P: High passage number, Low-P: Low passage
number. There was a signiﬁcant effect of exposure (p < 0.001) on both IL-6 and IL-8 secretion, and a signiﬁcant (p < 0.001) effect of cell density and passage number on IL-8
secretion.
* p < 0.05 compared to equivalent cell density.
+ p < 0.05 compared to VP and AIR.
# p < 0.05 compaired to AIR.
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to a range of subtoxic WS concentrations (ISO: 0.15–0.19 lg/cm2,
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Fig. 7. Percentage difference in toxicant yields following generation using the HCI smok
measurements. Data were analysed using 2 sample t-test. All toxicants derived from the
smoking regimen.and tissue remodelling mediators were measured and compared
to the AIR control. Regardless of regimen there was a signiﬁcant
increase in all inﬂammatory and tissue remodelling mediator
secretion at all doses, except for IL-6 at 0.15 lg/cm2, when com-
pared to the AIR control. To compare the secretion of inﬂammatory
mediators at ISO and HCI, comparisons were made at an equivalent
particulate dose of 0.19 lg/cm2. WS generated under the HCI reg-
imen induced a signiﬁcantly (p < 0.0001) greater IL-8 response
(HCI; 1139 ± 632 pg/mL, ISO; 661 ± 95 pg/mL) than WS generated
under the ISO smoking regimen (Fig. 10).4. Discussion
The conducting airway is made up of many cell types that con-
stitute the ﬁrst line of defence against the inhalation of external
environmental pollutants. It acts both as a physical and a300 400 500 600
ge difference to ISO smoking
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(smoke:air, vol:vol) for ISO and HCI generated 3R4F WS.
1726 D. Azzopardi et al. / Toxicology in Vitro 29 (2015) 1720–1728biochemical barrier and although it is thought to play a role in the
development of tobacco smoke-induced COPD (Patel et al., 2003;
Thorley and Tetley, 2007; Chen et al., 2010) the exact mecha-
nism(s) that lead to this condition are not fully understood. An
approach to investigate the early cytotoxic and inﬂammatory
responses of the bronchial epithelium to tobacco smoke exposure
is the use of bronchial epithelial cells transitioned to and exposed
at the ALI. This approach has previously shown promise in a num-
ber of cell culture systems (Beisswenger et al., 2004; Fukano et al.,
2004; Phillips et al., 2005; Maunders et al., 2007; Aufderheide,
2008; Mathis et al., 2013). However, for these cell cultures to be
used in the assessment of conventional tobacco products and next
generation tobacco and nicotine products, robustness and sensitiv-
ity studies are required to ensure that such cell culture systems are
ﬁt for purpose.
There have been many studies that have investigated the effects
of tobacco smoke exposure on lung epithelial cells. These have
used both cell lines (Weber et al., 2013) and primary cell cultures
(Mathis et al., 2013) in conjunction with various smoking machines
to deliver aerosols from combustible and non-combustible prod-
ucts. In the present study we used the NCI-H292 bronchial cell cul-
ture system (Phillips et al., 2005) because of its ease of cell culture,
its high throughput relative to primary cell cultures and because it
allows for the standardisation of the complete cell culture and
exposure system. The advantage of this system is that it is ﬂexible
with the potential to incorporate different ALI cultures, both cell
lines and primary cultures, when assessing a range of tobacco
products and nicotine delivery devices.-1 0 1 2
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Fig. 9. Cytotoxicity sigmoidal dose response curves for NCI-H292 cells exposed to
3R4F tobacco smoke generated at the ISO and HCI smoking regimens. There was a
signiﬁcant effect of smoking regimen on the EC50 (( ): ISO EC50 was 2.3 lg/cm2 and
the: ( ): HCI was 4.0; lg/cm2 p < 0.001).At the ALI, the bronchial cellswere found to be stable for up to 3 h
with cellular viability similar to that of the INC controls. Exposure of
cells to a relatively low ﬂow rate of sterile laboratory air for 30 min
had no signiﬁcant effect on viability when compared to the ALI con-
trol (0.5 h). There was a small, but signiﬁcant, reduction in viability
when compared to the INC control, even though viability levels
remained above 90%. We speculate that at the ﬂow rates used in
the current study, sufﬁcient humidity may be achieved above the
cells by the evaporation of culture medium. This may help preserve
ahighdegreeof cell viability evenduringa 30 minexposure to aﬂow
of continuous, 60%humid, sterile laboratory air. Althoughcell viabil-
ity was relatively unaffected by air exposure, IL-6 and IL-8, media-
tors identiﬁed as important in the pathogenesis of a number of
lung diseases (Chen et al., 2010; Patel et al., 2003; Thorley and
Tetley, 2007), were both signiﬁcantly increased compared to the
INCandALI cultures. These effects on cell viability and inﬂammatory
mediator releasehavebeenobservedpreviously (Knebel et al., 1998;
Beisswenger et al., 2004; Steinritz et al., 2013) andmay limit the sen-
sitivity and robustness of the assay. Thus careful considerationof the
cell lines and experimental conditions (exposure time, dose, sam-
pling time) used in the study is required to ensure meaningful data
is generated.
The in vitro cytotoxicity test used in this study utilises neutral
red which has previously been reported as the most sensitive assay
for assessing the cytotoxic potential of tobacco smoke (Putnam
et al., 2002). Using this assay we demonstrated that 89% of the
observed cytotoxicity of WS is derived from the VP and conﬁrms
previous results utilising WS in acute exposure models (Bombick
et al., 1997; Saladino et al., 1985; Fukano et al., 2004;). WS expo-
sure also induced an increase in the secretion of all three inﬂam-
matory mediators at all smoke doses which is in line with
previous observations made with this and other cell culture sys-
tems (Phillips et al., 2005; Beisswenger et al., 2004). Although
the inﬂammatory and tissue remodelling response following VP
exposure was lower when compared to WS exposure, IL-6 concen-
trations were signiﬁcantly lower than that observed for the AIR
control. This would indicate that the constituents of tobacco smoke
can both induce and potentially inhibit the secretion of some
inﬂammatory mediators following exposure. Thus to fully under-
stand the mechanism(s) that drive disease a knowledge of the
response of each constituent in tobacco smoke alone and in combi-
nation will be required.
The robustness of the model was assessed by determining the
cytotoxic and inﬂammatory response to WS and VP exposures fol-
lowing changes to the seeding density and cell passage number.
Passage number had a signiﬁcant effect on both cell viability and
inﬂammation, regardless of which fraction of smoke was used. In
AIR controls, IL-8 secretion was signiﬁcantly increased in cultures
derived from low passage numbered cells, an observation similar
to that seen followingWS and VP exposure. This corroborates stud-
ies that have addressed the effect of passage number on protein
expression in adenocarcinoma cells (Esquenet et al., 1997) and
on cell morphology in Caco-2 cells (Briske-Anderson et al., 1997).
Thus in any future studies experimental parameters, such as pas-
sage number will also need to be considered to ensure data vari-
ability is minimised prior to product assessment.
Whole smoke generated under the HCI regimen was found to be
less cytotoxic than equivalent doses expressed as lg PM/cm2 of
smoke derived from the ISO smoking regimen. In this model, the
cytotoxic effect of WS was primarily driven by VP components
and on HCI smoking there was a general reduction in the majority
of the particulate and VP toxicants when expressed per mg of TPM,
tar or nicotine (data not shown), an observation in agreement with
published studies (Roemer et al., 2012). All ISO and HCI exposures
resulted in a signiﬁcant increase in mediator release compared to
air controls and on comparison at a common dose of 0.19 lg/cm2,
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D. Azzopardi et al. / Toxicology in Vitro 29 (2015) 1720–1728 1727there was a trend towards increased IL-8 secretion following HCI
exposure. The reason for this is unclear. However, a number of
volatile aldehydes (crotonaldehyde and formaldehyde) are
increased relative to ISO smoking and as these compounds are
known to play a role in pulmonary inﬂammation (van der Toorn
et al., 2013), increased mediator secretion may be driven in part
by these constituents of the smoke. Further studies are required
to fully determine the effect of these aldehydes in the response
of lung cells to WS exposure.
In this study a simple ALI bronchial cell culture system has been
assessed following a 24 h recovery period as a potential tool for
future tobacco product testing. To fully explore the potential of this
cell culture system will also require potential changes in exposure
time, WS and VP dose and additional assessments at earlier (<24 h)
and possibly later time points following exposure. The cell culture
system was able to differentiate between WS and VP with respect
to cytotoxicity and inﬂammatory response. In addition, it was also
able to differentiate between smoking regimens with regard to
cytotoxicity. Due to the inhibitory action of VP on IL-6 release
and the increased inﬂammatory response of smoke generated
under the HCI smoking regime, further studies are needed to
understand the role of individual smoke toxicant and toxicant mix-
tures on this process and the subsequent potential for inducing dis-
ease. Finally, although this cell culture exposure system enables
rapid screening of aerosols from different combustible tobacco
products generated under different exposure regimens, to fully
understand the mechanisms that lead to tobacco smoke induced
injury and disease, further studies will require a combined
approach using more traditional exposure matrices such as cigar-
ette smoke extracts and TPM. We have demonstrated the current
cell culture exposure system is ﬂexible, sensitive, robust and future
studies with conventional tobacco products and next generation
tobacco and nicotine products and more physiologically relevant
ALI cell culture models will be undertaken.Conﬂict of Interest
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